Advertisement

Topics

Miltenyi Biotec GmbH Company Profile

13:48 EDT 18th June 2018 | BioPortfolio

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s innovative tools support research at every level, from basic research to translational research to clinical application. This complete portfolio enables scientists and clinicians to access, analyze, and utilize primary cells and primary-derived cells. Their integrated technologies that cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Trusted around the world, the MACS® brand continues to set new standards in the industry. The company’s more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In their commitment to supporting the scientific community, Miltenyi Biotec also offers comprehensive scientific support and expert training through their MACS Academy. Miltenyi Biotec has more than 1,300 employees in 22 countries.

Location

Friedrich-Ebert-Strasse 68
Bergisch Gladbach,
51429
Germany

Contact

Phone: 49 2204 8306-0
Fax: 49 2204 85197
Email: macs@miltenyibiotec.de


News Articles [177 Associated News Articles listed on BioPortfolio]

Miltenyi Biotec Will Highlight Tools for Dissecting the Tumor Microenvironment in a Two-part Webinar Series

LabRoots will host the webinar May 24, in which attendees will gain a better understanding on how isolation of tumor subpopulations will enhance NGS based analyses. YORBA LINDA, Calif. (PRWEB) May 01,...

Biopharma company signs agreement to support production of cell therapies

Clinical-stage biopharmaceutical company, Autolus, and provider of products and services for biomedical research and cellular therapy, Miltenyi Biotec, have signed a strategic long-term supply agreeme...

Miltenyi Biotec Sponsors Educational Webinar on Tools for Isolation and Flow Analysis of Cells Within the Tumor Microenvironment

In this webinar hosted by LabRoots on May 29, 2018, participants will discover best practices for isolation of tumor infiltrating leukocytes (TILs) and learn about an optimized workflow for faster and...

Autolus pairs up with Miltenyi to manufacture T-cell therapies

Autolus aims to automate its cell processing steps utilizing Miltenyi tools, which could in theory make the complex manufacturing process more reproducible.

Educational Webinar: Miltenyi Biotec Highlights the Benefits of Isolating Immune Cells Directly From Whole Blood

In this webinar, which LabRoots will host June 28, attendees will gain a better understanding of how to isolate target cells directly from blood or blood products with preserved functionality. YORBA L...

Miltenyi Biotec GmbH Medical Equipment Deals and Alliances Profile [Report Updated: 21122017] Prices from USD $250

SummaryMiltenyi Biotec GmbH Miltenyi is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture...

Miltenyi Biotec GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13032018] Prices from USD $250

SummaryMiltenyi Biotec GmbH Miltenyi is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture...

BRIEF—Panacea Biotec and Serum Institute of India in historic link

Indian vaccines producer Panacea Biotec Ltd. (PBL) has signed two long-term collaboration agreements…

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Comparison of Synthetic Media Designed for Expansion of Adipose-Derived Mesenchymal Stromal Cells.

Mesenchymal stromal cells (MSCs) are multipotent cells that can differentiate into various cell types, such as osteoblasts, myocytes, and adipocytes. This characteristic makes the cells a useful tool ...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Clinical Trials [72 Associated Clinical Trials listed on BioPortfolio]

Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)

Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec) device, rath...

Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

Evaluate the safety of NK cell infusion using CD56 monoclonal antibody selected with Miltenyi Biotec system following nonmyeloablative stem cell transplantation from mismatched donors. Thi...

Unrelated/Partially Matched Related Donor Peripheral Stem Cell Transplantation With CliniMACs Device for T-cell Depletion

This is a pilot study with 2 strata to evaluate engraftment and graft vs. host disease (GVHD) in patients receiving unrelated or partially matched related donor peripheral stem cells with ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders

This is a study to evaluate the safety and efficacy of Miltenyi CliniMACS® CD34 Reagent System to promote engraftment of haploidentical CD34+ selected cells combined with single unit umbi...

Companies [545 Associated Companies listed on BioPortfolio]

Miltenyi Biotec GmbH

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s innovative tools support research at every level, from basic ...

AC Biotec GmbH

The company AC Biotec GmbH is a provider in the field of bioprocess development, contract manufacturing and technology consulting. As a commercial service AC Biotec offers development, optimization an...

Richter-Helm BioTec GmbH & Co. KG

"Richter-Helm is a dynamic and expanding biotechnology company located in Hamburg, Germany. The company was founded in 1997 as Strathmann Biotec and was acquired by a joint-venture of Gedeon Richter P...

Biotec Pharmacon ASA

Biotec Pharmacon develops, manufactures, and markets immune modulating compounds and molecular biology grade enzymes, based on own research in immunology and marine biotechnology.

Biotec Distribution Ltd

Biotec Distribution Wales Ltd is a UK based Clinical Trials Supply company specialising in the storage and distribution of temperature sensitive biopharmaceuticals.

More Information about "Miltenyi Biotec GmbH" on BioPortfolio

We have published hundreds of Miltenyi Biotec GmbH news stories on BioPortfolio along with dozens of Miltenyi Biotec GmbH Clinical Trials and PubMed Articles about Miltenyi Biotec GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Miltenyi Biotec GmbH Companies in our database. You can also find out about relevant Miltenyi Biotec GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record